Clinical Trials Arena on MSN13h
Antag commences trial of GIPR antagonist for treating obesityAntag Therapeutics has initiated a first-in-human, double-blind Phase Ia trial of the glucose-dependent insulinotropic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback